ANDA 40065, held by Bausch & Lomb. Prednisolone Sodium Phosphate.
As of Nov 21, 2026, ANDA 40065 (Prednisolone Sodium Phosphate), held by Bausch & Lomb, was first approved by FDA on Jul 29, 1994, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 29, 1994 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisolone Sodium PhosphateEQ 0.11% PHOSPHATE · solution/drops;ophthalmic | Prednisolone Sodium Phosphate | Discontinued |
| Nov 27, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Mar 7, 2001 | Supplement 8Manufacturing | Approved | None posted |
| Oct 5, 2000 | Supplement 7Manufacturing | Approved | None posted |
| Jun 27, 2000 | Supplement 6Manufacturing | Approved | None posted |
| May 18, 2000 | Supplement 3Manufacturing | Approved | None posted |
| Apr 28, 2000 | Supplement 4Manufacturing | Approved | None posted |
| Jun 7, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Jul 29, 1994 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters